China National Nuclear Corporation Capital

The firm invests across the nuclear fuel cycle, including advanced reactor design, small modular reactors, nuclear medicine and isotopes, precision manufacturing for reactor components, and uranium mining assets. It also targets adjacent industrial technology where the parent's engineering expertise provides an edge, such as automation and materials science. Public records indicate recent interest in nuclear fusion startups and radiopharmaceutical companies.

The majority of portfolio companies are domestic, concentrated in nuclear industry clusters in Zhejiang, Guangdong, and Shandong provinces. However, the mandate includes outbound investment in uranium mining and fuel fabrication, with known partnerships in Kazakhstan and Namibia that support CNNC's upstream fuel security strategy.

The firm operates with a dual mandate of generating financial returns and advancing China's national energy security objectives. Its investment decisions are subject to strategic review, and the pace of deployment accelerates when nuclear power is prioritized in China's Five-Year Plans. This policy-linked posture makes it distinct from purely return-driven private equity firms.

Yes, the firm invests across the full spectrum from seed-stage ventures to late-stage industrial scale-ups. Early-stage commitments have historically targeted next-generation fission concepts, fusion research, and isotope production technology. Growth-stage capital is directed toward proven nuclear supply chain companies that are scaling manufacturing capacity.